The interleukin 3 (IL-3), I1:5, and granulocyte/macrophage colony-stimulating factor receptors consist of a cytokine-specific c~ subunit and the common 3 subunit. Whereas IL-3 stimulates various lineages of hematopoietic cells, including muhipotential progenitors, I1:5 acts mainly as an eosinophil lineage-specific factor. To investigate whether the lineage specificity of II.-5 is due to restricted expression of the I1:5 receptor ol subunit (I1:5Rc 0, we generated transgenic mice that express the mouse I1:5Kc~ constitutively by phosphoglycerate kinase promoter. The transgenic mouse expressed I1:5P, oc ubiquitously, and the bone marrow cells formed various types of colonies, including multi-lineage colonies, in response to IL-5.11,5 also supported formation of both multi-lineage and blast cell colonies from dormant progenitors of the 5-fluorouracil-treated transgenic mice. The cells composing the blast cell colony gave rise to many colonies including muhi-lineage colonies when they were replated in secondary culture containing either I1:5 or I1:3. There was no significant difference in replating efficiency or in types of secondary colonies between I1:5-and I1:3-stimulated cultures. Conversely, the cells from the I1:3-induced blast cell colonies of the transgenic mice proliferated in response to either I1:3 or IL-5. Thus, the development of the progenitors can be equally supported by either I1:5 or I1:3, suggesting that intracellular signals from the I1:3R can be replaced by those from IL-5. These results strongly suggest that the lineage specificity of I1:5 is mainly due to the restricted expression of I1:SRol.
I
1:3, I1:5, and GM-CSF exhibit similar functions on their common target cells such as eosinophils (1) (2) (3) . These common functions are believed to be mediated by the shared receptor subunit (4) (5) (6) (7) (8) . The high-affinity receptors for I1:3, I1:5, and GM-CSF are composed of a cytokine-specific ol subunit (8) (9) (10) and the common B subunit; both are members of the class I cytokine receptor family. The oe subunits bind their specific cytokine with only low affinity and form highaffinity receptor with the common ~ subunit (Be) 1. The ~c subunit by itself has no significant binding to any of these cytokines but is essential for high-affnity binding as well as signal transduction. Whereas there is only the common subunit in the human receptors, the mouse has an additional I1:3-specific B subunit (/~rL3, also known as AIC2A) that is 91% identical to the mouse ~/c (also known as AIC2B) at 1 Abbreviations used in this paper: 8r common 3 subunit; 31L3, IL-3-specific B subunit; BMC, bone marrow cell; Epo, erythropoietin; FU, fluorouracil; IL-3Ro~, IL-3Rc~ subunit; PGK-1, phosphoglycerate kinase 1. the amino acid level (11) . The two/~ subunits are coexpressed on various hematopoietic cells. Interestingly, however,/3IL3 itself binds mouse I1:3 with low affnity and interacts with only I1:3Ro~ subunit (I1:3Ro 0 (10). The physiological role of ~IL3 in the mouse remains unknown.
Whereas I1:3, II:5, and GM-CSF exhibit similar functions on target cells such as eosinophils, they also have their individual functions. I1:3 stimulates hematopoietic stem cells as well as various lineage-committed progenitors including granulocytes, macrophages, eosinophils, mast cells, megakaryocytes, and erythroid cells (12) , so I1:3 is also known as multi-CSE GM-CSF was originally defined as a factor that stimulates colony formation of granulocytes and macrophages. Subsequent studies, however, have shown that GM-CSF interacts with a much broader range of cells including uncommitted multipotential progenitors (13) . In contrast, I1:5, originally found as a B cell differentiation factor that stimulates production of IgM and IgA in mouse (14, 15) , has a major role in eosinophil development in both mouse and human, and primitive hematopoietic progenitors do not respond to Ib5 (16) . IL-5 supports only a few eosinophil colonies in semisolid cultures of mouse normal bone marrow cells (BMC) or spleen cells.
These functional differences may be due to different means of signal transduction among the three ot subunits. Alternatively, because the three ot subunits are equivalent in signaling, the differential response to cytokines may be due to differential expression of the o~ subunits. We have approached this question by generating transgenic mice expressing the Ib 5gc~ ubiquitously. BMC from the IbSP, ot transgenic mouse formed colonies of multiple lineages in response to Ib5, indicating that Ib5ot has a potential similar to IL-3Rot when it is expressed on early progenitors. Thus, the lineage-restricted response of BMC to II.-5 is most likely due to the restricted expression of II.-5Rot on eosinophils.
Materials and Methods

Construction of the Phosphoglycerate Kinase 1-IL5Rce Gene and Pwduction of Transs
Mice. An XhoI fragment carrying mouse IL-5Rot eDNA in plb5R.8 plasmid (9) was placed between the phosphoglycerate kinase (PGK) 1 promoter (17) and the SV40 early polyadenylation signal (Fig. 1) . The plasmid vector for the PGK-1 promoter was provided by R. Murray (DNAX). A purified BamHI fragment containing PGK-Ib5Rot was microinjected into pronuclei of fertilized eggs of C57BL/6 x SJL F2 hybrid mice as described (18) by DNX, Inc. (Princeton, NJ). Transgenic mice were screened by PCR and Southern blot analysis of tail DNA using an entire Ib5Rc~ eDNA fragment as a probe, as described previously (19) .
PCR. reaction was performed by using AmpliTaq DNA polymerase (Perkin Elmer-Cetus, Norwalk, CT), 20 pmol of primers, and 1 gg tail DNA for 30 cycles (94~ 1 rain, 52~ 2 min, 720C 3 rain), followed by 10 min at 72~ Oligonucleotide primers, P1 and P2, are shown in Fig. 1 . The 5' primer (Pl: 5'ACGCTTCAA-AAGCGCACGTCTY) was in the PGK-1 promoter gene, and the 3' primer (P2: 5'AACTTGAGCTAATCCAG~Y) was in the Ib5Rc~ gene. PCR products were electrophoresed on 1.5% agarose gels and stained with ethidium bromide. The expected size of the PCR product was 541 bp, and the identity of the PCR product was confirmed by digestion with either HindlII or Xhol.
RT-PCR.
Total RNAs were isolated from various tissues and cells using the acid-guanidinium-phenol-chloroform protocol (20) (Clontech Laboratories, Palo Alto, CA). Polyinosinic acid (10 gg) was added as a carrier when RNA was extracted from blast cell colonies. In all cases, RNA preparations were subjected to a DNase I (GenHunter, Brookline, MA) digestion step before eDNA synthesis, thus eliminating any remaining genomic DNA. Total RNA was reverse transcribed using a First-Strand eDNA Synthesis Kit (Pharmacia, Piscataway, NJ) for 1 h at 37~ PCR was performed by using Pl and P2 primers under the same conditions as described above. To check for genomic DNA contamination, a control reaction with heat-inactivated reverse transcriptase was always included.
Flow CTtoraetry. BMC from transgenic mice and their normal littermates were prepared after removing red blood cells using ammonium chloride buffer solution. A mydoid call line, OTT1 (21) , was maintained in RPMI medium containing 10% FCS (Sigma Chemical Co., St Louis, MO), 50 gM 2-ME (Sigma Chemical Co.) and 10 ng/ml mouse I1--3. Cells (106) in 50 gl of PBS containing 5% FCS were incubated with 1/zg of purified mAb, H7 (rat IgG2a), which recognizes Ib-5Rot (22) CellPreparation. Single-cell suspensions were prepared from bone marrow or spleen of 6-8-wk-old mice. BMC were flushed from femurs and tibiae into a-medium (GIBCO BRL, Gaithersburg, ME)) by using a 26-gauge needle. Spleen cells were prepared by teasing the spleen in 3 ml of c~-medium in a 35-mm suspension culture dish (model 171099; Nunc, Inc., Naperville, IL) and by repeated pipetting. Either BMC or spleen cells were passed through a 70-#m nylon cell strainer (model 2350; Becton Dickinson Labware, Franklin Lakes, NJ).
5-fluorouracil (FU) (Sigma Chemical Co.) was administered through tail veins of mice at a dosage of 150 mg/kg body weight (23) . Spleen cells and BMC were harvested 4 d and 2 d after the 5-FU injection, respectively.
Growth Factors. Recombinant mouse II.-3 and GM-CSF were produced in silkworm and yeast, respectively (24, 25) . Recombinant mouse IL-5, human I1.-6, and human erythropoietin (Epo) were purchased from R&D Systems, Inc., (Minneapolis, MN). Unless otherwise specified, concentrations of growth factors used in this study were as follows: II.-3, 10 ng/ml; II.-5, 100 ng/ml; GM-CSF, 10 ng/ml; Ib6, 100 ng/ml; Epo, 2 U/ml.
Clonal Cell Cultures.
Methylcellulose culture was carried out in 35-mm suspension culture dishes (model 171099, Nunc, Inc.). 1-ml of culture mixture consisted of 2 x 104 BMC from 5-FUuntreated mice, 5 x 104 BMC from 5-FU-treated mice, or 1 x 106 spleen cells from 5-FU-treated mice; o~-medium; 0.9% 4000 centipoises methylcellulose (Fisher, Norcross, GA); 30% FCS (Hyclone Laboratories, Logan, UT); 1% deionized, fraction V BSA (Sigma Chemical Co.); 100 ~tM 2-ME; and hematopoietic growth factors. In a serum-flee culture, FCS was replaced with a combination of 1% deionized crystallized BSA (Sigma Chemical Co.), 300 gg/ml 30% iron-saturated human transferrin (Boehringer Mannheim), 160 #g/ml soybean lecithin, 96 #g/ml cholesterol and 100 nM sodium selenite (all from Sigma Chemical Co.); fraction V BSA was omitted. Dishes were incubated at 37~ in a humidified atmosphere with 5% CO2 in air. Colony types were determined on day 16 of incubation by in situ observation on an inverted microscope according to the criteria described previously (26). Except for megakaryocyte colonies, colonies consisting of/>50 cells were scored. Abbreviations of colony types are as follows: GM, granulocyte/macrophage colonies; M~, macrophage colonies; Eo, eosinophil colonies; GMM, granulocyte/macrophage/megakaryocyte colonies; GEM, granulocyte/erythrocyte/macrophage colonies; GEMM, granulocyte/erythrocyte/macrophage/megakaryocyte colonies; EM, erythrocyte/megakaryocyte colonies; Meg, megakaryocyte colonies; BFU-E, erythroid bursts; and Mast, mast cell colonies.
Replating Experiments. To determine the potential of the blast cell colonies, we carried out replating experiments of individual blast cell colonies developed in cultures of spleen cells from 5-FUtreated normal or transgenic mice. Individual blast cell colonies developed on day 7 of incubation in the presence of Ib5 or Ib3 were picked up with a micropipette (Eppendorf North America, Inc., Madison, WI) on an inverted microscope, resuspended in 100/zl of or-medium, gently pipetted, and divided into three parts. Each aliquot of the ceU suspension was added to secondary culture medium containing Ib3 plus Epo, IL-5 plus Epo, or Epo alone. Replated cells were cultured and secondary colonies were scored in the same manner as primary cultures.
R e s u l t s
Production of Mouse IL5R~ Transgen~ Mice. To express IL-5Rot in immature hematopoietic progenitor cells constitutively, we used the PGK promoter since PGK is a housekeeping enzyme that is expressed at a high level in virtually all cell types (27) and the PGK-1 promoter is highly active in embryonic tissues, especially in mouse embryonic stem (ES) cells (28) . To generate transgenic mice, a 2.6-kb DNA fragment containing mouse PGK-1 promoter, mouse II.-5Ro~ cDNA, and SV40 early poly A tail (Fig.l) was microinjected into C57BL/6 x SJL F2 hybrid mouse eggs. For screening transgenic mice, tail DNA was analyzed by PCR with oligonucleotide primers, Pl and P2 (Fig.l) . Integration of the transgene was then confirmed by Southern blot analysis with entire mouse II~5Rol cDNA as a probe (data not shown). Four founder mice were found to carry the mouse IL-5Rol transgene (Nos. 5, 12, 13, and 18) among 20 offspring. By crossing to C57BL/6 mice, two (Nos. 5 and 13) of them transmitted the transgene to half of their offspring, regardless of their sex.
Expression of mouse IL-5Rcr Gene in Transgenic Mice. RT-
PCR analysis was performed to examine expression of the transgene. To ensure that the PCR products were actually derived from RNA, the extracts from various tissues were treated with DNase I before reverse transcriptase reaction. PCR was performed for 30 cycles. Control PCR using heatinactivated reverse transcriptase was also performed to check genomic DNA contamination. We used the same primers as those for the tail DNA screening, which covered both PGK-1 promoter and II~5Ra cDNA. No PCR product was obtained in normal littermate mice (data not shown). The IL-5Rc~ transgene was expressed ubiquitously in transgenic mice derived from the No. 13 mouse (Fig. 2) . Expression of the IL-SRot transgene in BMC was also confirmed by using a mAb, H7 (22) . Approximately 20% of the BMC of transgenic mice from No. 13 were stained with H7 (Fig. 3) . In contrast, IL-5Rol expression was hardly detected in transgenic 
Dose-dependent Effect ofll_,5. BMC of the transgenic mouse
formed colonies in an IbS-dependent manner (Fig. 4) . I1-5 stimulated only a few eosinophil colonies from BMC of normal mice. In contrast, various types of colonies were formed in response to IF5 from the IL-5Rot transgenic mice. The number of colonies reached the maximal level at 100 ng/ml IL-5. At this concentration, the total number of colonies was comparable with that of colonies supported by the optimum con- centration of Ib3. Thus, we employed 100 ng/ml II.-5 to analyze the effect of I1.,5 more precisely on the hematopoietic progenitor cells of Ib51Lot transgenic mice in subsequent studies.
IL.5-dependent Hematopoietic Colony Formation.
The number of GM and macrophage colonies supported by GM-CSF was almost the same between the transgenic mice and the normal littermates, ensuring that an equal number of progenitor cells was plated in a dish in this experiment (Fig.  5 A) . As reported previously (12, 16), II.-5 supported the growth of a small number of eosinophil colonies from BMC of normal mice, whereas various types of colonies developed in the presence of II.-3. In contrast, both Ib5 and IL-3 equally stimulated development of GM, M<k GMM, Meg, and Mast colonies from BMC of transgenic mice (Fig. 5 B) . Several eosinophil colonies were also formed in the culture of BMC of the transgenic mice in the presence of IL-5. Numbers and size did not exceed the eosinophil colonies derived from normal mice upon II. to substitute for Epo. In the presence of Epo, IL-5 as well as IL-3 supported the formation of BFU-E and multi-lineage colonies containing erythroid cells such as GEM, GEMM, and EM colonies ( Fig. 5 C and Fig. 6 ). We also examined IL-5-induced colony formation from BMC of the transgenic mouse in serum-free condition, because FCS may contain various types of hematopoietic growth factors (29) (30) (31) (32) . Again, the effects of IL-3 on hematopoietic colony formation were completely replaced by IL-5 in the serum-free culture of BMC of the transgenic mice (Fig. 7) .
Colony Formation from BMC of 5-FU-treated Mice. To in-
vestigate the effects of Ib5 on the development of primitive hematopoietic progenitors, we used BMC of 5-FU-treated mice. It is well established that the cell cycle of dormant progenitor cells is regulated by early acting cytokines such as IL-6, G-CSF, IL-11, leukemia inhibitory factor, I1:12, and stem cell factor (33) . IL-3 is known to support the proliferation of multi-lineage progenitors when they exit from Go (12), and IL-3 supported formation of a few multi-lineage colonies from 5-FU-treated BMC of both normal and transgenic mice ( (Fig. 9 ). Individual blast cell colonies were lifted on day 7, suspended in o~ medium, and divided into three parts. Each aliquot of the cell suspension was added to secondary culture medium containing IL-3 plus Epo, IL-5 plus Epo, or Epo alone. Blast cell colonies supported by Ib5 responded not only to II.-5 but also to Ib3 and gave rise to secondary colonies (Table 1) . Conversely, Ib3-induced blast cells responded to either II~3 or IIr As previously reported (12, 36) , very heterogeneous distribution of secondary colonies, including the incidence of GEMM colonies, was observed.
On the other hand, the blast cells showed similar replating efficiency and similar distribution of secondary colony types when they were divided and individually replated in the secondary culture containing either II.-3 or II~5. There was no significant difference in the fate of the blast cells regardless of whether Ib3 or Ib5 was used as a second stimulus. In contrast to the transgenic mice, blast cell colonies were developed in the culture of spleen cells of the 5-FU-treated normal mice in the presence of IL-3, but not in the culture with Ib5. Normal mice-derived blast cell colonies supported by Ib3 gave rise to very few or no secondary colonies upon stimulation with IL-5, whereas II:3 supported many secondary colonies including muhi-lineage colonies from the same blast cells (Table 2) .
These results indicate that 5-FU-resistant dormant hematopoietic progenitors of transgenic mice actually express both IL-3 and IL-5 receptors on their surface and that development of the progenitors can be equally supported by either Ib3 or IL-5. Results of replating studies also show that Ib5-induced formation of multi-lineage colonies results from direct action of IL-5 on progenitor cells, but not through accessory cells such as macrophages and lymphocytes, because blast cell colonies are devoid of any accessory cells or stromal cells.
Discussion
Whereas IL-3, GM-CSF, and Ib5 exhibit some similar functions on eosinophils and basophils (37, 38) , there are also remarkable functional differences among them. In particular, some functions of IL-3 and II.-5 are quite different. We have previously demonstrated that the functional high-affinity receptors for IL-3, IL-5, and GM-CSF are composed of or and 3 subunits (39). The ot subunits are cytokine specific, each cytokine having its own specific ot subunit. There are two distinct fl subunits in the mouse; tic is shared by these three receptors, whereas flIL3 is specific to the IL-3 receptor. Thus, the marked difference of the biological activities between IL-3 and II75 may be due to cellular signaling differences between cytokine-specific o~ subunits or between flIL3 and tic. Alternatively, the difference may simply reflect the different pattern of expression of the ot subunits. These possibilities may be distinguished by analyzing receptor expression. Whereas a wide distribution of IL-3Rc~ in hematopoietic cells has been reported (10), anti-IL-SRot antibody did not show significant staining of BMC (40) (Fig.  3) . However, expression studies may not provide conclusive evidence to discriminate between the two possibilities, as the receptor expression can be measured only to a certain limit of sensitivity. Instead of studying receptor expression directly, we have approached the question by generating a transgenic mouse expressing the IL-5Rot constitutively. We have used the PGK promoter to express IL-5Rot, as PGK is a housekeeping enzyme that is present in various tissues constitutively. In fact, we detected IL-5Rot in various tissues of the transgenic mouse, where at least 20% of total BMC were stained with the anti-Ib5Rot antibody. IL-5Rcr was expressed in blast cells from transgenic mice, which have the potential to differentiate to various lineages.
By using the BMC of transgenic mice, we have shown that IL-5 is able to support development of multi-potential progenitor cells without induction of preferential differenti-ation toward the eosinophil lineage in the Ib5Rot transgenic mouse. IL-5 supported formation of various types of colonies in methylcellulose culture of BMC from the IL-5Rot transgenic mice. These colonies included not only eosinophil colonies, but also GM, macrophage, GMM, Meg, and Mast colonies. There was no difference in number or size of IL-5-induced eosinophil colonies between the normal and the transgenic mice. Ib5 induced the colony formation of blast cells with no signs of terminal differentiation from 5-FU-treated spleen cells of the transgenic mice on day 7 of incubation. Our replating studies of individual blast cell colonies clearly demonstrated that proliferation of CFU blasts of the IL-5Rot transgenic mouse and their differentiation to terminal cells are equally supported by either IL-5 or IL-3, and that switching the cytokine from Ib5 to IL-3, or from Ib3 to Ib5 does not affect the differentiation of blast cells.
These results indicate that intracellular signals from the IL-3 receptors can be replaced with those from the Ib5 receptor and that the restricted response of the normal mouse BMC to IL-5 is likely due to the restricted expression of Ib5Rc~. Thus, the progenitors do not appear to require IL-3Rot chain-specific or fliL3-Specific signals for their hematopoietic development, and tic together with IL-SRot is able to transduce essential signals for the development of multi-lineage hematopoietic progenitors. However, our results do not exclude the possibility that each ot subunit and filL3 plays a specific role in hematopoietic development, which may not be obvious by the in vitro colony assays employed in this study. To further investigate the role of filL3 or /3~ in the development of hematopoietic cells, knockout mice that lack either of the two fl genes will be useful.
Recently, Dubart et al. (41) introduced the normal Epo receptor (EpoR) cDNA into mouse BMC using a retrovirus vector and analyzed growth of pluripotent progenitors upon Epo stimulation. Epo is a lineage-specific cytokine whose function is usually limited only to the proliferation and differentiation of late erythroid progenitors. They observed that the EpoR-infected BMC responded to Epo alone and gave rise to mixed colonies including erythrocytes, granulocytes, macrophages, and megakaryocytes. The mixed colonies contained the cells with a potential to form secondary colonies. These results indicate that EpoR is capable of stimulating the multipotential progenitors without restricting their differentiation potential to only an erythroid lineage. These results are consistent with our results using the IL-SRot transgenic mouse and are also consistent with the results that EpoR and IL-3/ IL-5/GM-CSF receptors share many common signaling pathways (42, 43) .
However, there is a significant difference between EpoRinfected BMC and the IL-SRot transgenic mouse. Epo alone supported erythrocyte development in the EpoR-infected BMC, whereas IL-3 or Ib5 alone did not support erythrocyte development. Whereas IL-5Rot is expressed constitutively in the transgenic mouse, II:5 response absolutely depends on the presence of tic. Thus, the difference may be due to the lack of B~ at a late stage of erythrocyte differentiation. Alternatively, there may be a difference in signaling pathways between EpoR and Ib3/IL-5/GM-CSF receptors. The mouse Table 1 for details. Note that IL-5 could not support blast cell colony formation from spleen cells of normal littermates.
Ib3-dependent BaF3 transfected with the EpoR proliferated in response to either I1:3 or Epo, whereas only Epo induced globin synthesis (44, 45) , indicating a difference in signaling pathways. Therefore it is possible that Epo-specific signaling is required for a late stage of erythrocyte differentiation. Whereas it is not clear from the report by Dubart et al. (41) whether Epo can support eosinophil differentiation in the EpoR-infected BMC, terminal differentiation of eosinophils may also require I1:5-specific signaling. These observations collectively suggest the possibility that cytokines such as
I1:3/I1:5/GM-CSF or Epo induce proliferation signals in early
hematopoietic progenitors expressing their receptors but may not instruct the direction of differentiation. Cytokine-specific signals may be required after commitment to a particular lineage such as erythrocytes or eosinophils. It is well established that II:3 and I1:6 synergistically stimulate formation of multi-lineage colonies (34, 35) . Whereas I1:5 alone supported formation of a few multi-lineage colonies from BMC of the 5-FU-treated transgenic mice, a marked synergy between I1:5 and Ib6 was observed. As the multipotential progenitors appear to express 1b5Ro~ constitutively, synergy by 11:6 is probably not due to upregulation of the ol subunit. Recently, McClanahan et al. (46) analyzed patterns of expression of various cytokine receptor genes in developing embryoid bodies from ES cells. They demonstrated that genes for Ib3Rc~ and GM-CSFRc~ are expressed constitutively in ES cells, as well as across the entire time course of embryoid body development. In contrast, ~o and 31r3 are upregnlated in day 7 embryoid bodies. Thus, it is possible that I1,6 stimulates the transition of hematopoietic progenitors from the dormant Go stage to a cycling stage and that this transition is accompanied by upregnlation of the subunits. The marked synergy between I1:5 and Ib6 may result from enhanced formation of high-af~nity receptors by association of II.-5Ro~ to the upregulated 3 subunits on the progenitors. BMC from transgenic mouse expressing not only an c~ subunit but a ~ subunit may provide a unique system for analyzing these questions.
We thank Drs. T. Nakahata, T. Yokota, and K. Arai (Institute of Medical Science, University of Tokyo) for discussion and critical reading of the manuscript.
